Public Employees Retirement Association of Colorado Lowers Position in Illumina, Inc. (ILMN)

Public Employees Retirement Association of Colorado reduced its stake in shares of Illumina, Inc. (NASDAQ:ILMN) by 2.6% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 28,246 shares of the life sciences company’s stock after selling 761 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Illumina were worth $4,820,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of ILMN. Baillie Gifford & Co. boosted its position in Illumina by 1.0% in the fourth quarter. Baillie Gifford & Co. now owns 18,766,712 shares of the life sciences company’s stock valued at $2,402,890,000 after buying an additional 178,559 shares in the last quarter. Capital Research Global Investors increased its stake in shares of Illumina by 2.1% in the third quarter. Capital Research Global Investors now owns 13,360,554 shares of the life sciences company’s stock valued at $2,427,078,000 after buying an additional 275,483 shares during the period. Edgewood Management LLC increased its stake in shares of Illumina by 33.6% in the fourth quarter. Edgewood Management LLC now owns 6,639,776 shares of the life sciences company’s stock valued at $850,157,000 after buying an additional 1,671,293 shares during the period. Jennison Associates LLC increased its stake in shares of Illumina by 69.0% in the first quarter. Jennison Associates LLC now owns 5,254,274 shares of the life sciences company’s stock valued at $896,589,000 after buying an additional 2,144,576 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Illumina by 3.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 4,632,576 shares of the life sciences company’s stock valued at $841,554,000 after buying an additional 140,411 shares during the period. 92.79% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Illumina (NASDAQ:ILMN)

Shares of Illumina, Inc. (NASDAQ:ILMN) traded up 0.84% during mid-day trading on Friday, reaching $177.37. 632,100 shares of the company’s stock traded hands. The stock has a market cap of $25.90 billion, a PE ratio of 35.90 and a beta of 0.79. Illumina, Inc. has a 12 month low of $119.37 and a 12 month high of $189.48. The firm has a 50 day moving average price of $178.41 and a 200-day moving average price of $156.53.

Illumina (NASDAQ:ILMN) last posted its earnings results on Tuesday, April 25th. The life sciences company reported $0.64 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.64. Illumina had a net margin of 19.31% and a return on equity of 22.89%. The firm had revenue of $598 million for the quarter, compared to analyst estimates of $590.51 million. During the same period in the previous year, the firm posted $0.71 EPS. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, analysts predict that Illumina, Inc. will post $3.63 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Public Employees Retirement Association of Colorado Lowers Position in Illumina, Inc. (ILMN)” was first published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece on another website, it was illegally copied and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.chaffeybreeze.com/2017/05/19/public-employees-retirement-association-of-colorado-has-4-82-million-position-in-illumina-inc-ilmn-updated.html.

Several analysts have issued reports on the stock. Vetr raised shares of Illumina from a “buy” rating to a “strong-buy” rating and set a $196.75 target price on the stock in a research note on Monday, April 24th. Zacks Investment Research downgraded shares of Illumina from a “buy” rating to a “hold” rating in a research note on Thursday, April 13th. Evercore ISI raised shares of Illumina from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Monday, February 27th. Leerink Swann upgraded shares of Illumina from a “market perform” rating to an “outperform” rating and set a $195.00 price target on the stock in a report on Monday, March 20th. Finally, Deutsche Bank AG restated a “hold” rating and set a $175.00 price target (up from $165.00) on shares of Illumina in a report on Saturday, April 29th. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Hold” and an average price target of $164.97.

In other news, Director A Blaine Bowman sold 2,300 shares of the company’s stock in a transaction on Wednesday, May 10th. The shares were sold at an average price of $181.61, for a total value of $417,703.00. Following the sale, the director now directly owns 18,004 shares of the company’s stock, valued at approximately $3,269,706.44. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Charles Dadswell sold 1,609 shares of the company’s stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $187.07, for a total transaction of $300,995.63. Following the completion of the sale, the senior vice president now directly owns 10,936 shares in the company, valued at $2,045,797.52. The disclosure for this sale can be found here. Insiders have sold a total of 35,521 shares of company stock worth $6,465,772 over the last three months. Insiders own 1.60% of the company’s stock.

About Illumina

Illumina, Inc (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations.

5 Day Chart for NASDAQ:ILMN

Receive News & Ratings for Illumina Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Illumina Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply